Bristol-Myers Squibb Co. (NYSE:BMY)

Medicine pills

Major Pharma Has Short Sellers on the Run

The short interest data have been released for the May 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

How Credit Suisse Views Major Pharma After ASCO

The American Society of Clinical Oncology (ASCO) annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations ...
Read Full Story »
Female patient on gurney

Merrill Lynch Picks ASCO Winners

The health care sector is descending on Chicago as the American Society of Clinical Oncology (ASCO) annual meeting nears. This meeting draws many companies and analysts alike, looking for the ...
Read Full Story »
Doctor, Health (pulse) copy

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is in the process of gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their ...
Read Full Story »
Pfizer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Needless to say, the health care sector, especially pharmaceuticals and biotech, have taken a rhetorical beating from politicians looking to force the blame for high drug prices on some of the ...
Read Full Story »
white pills

Short Sellers Take Mixed Stance on Major Pharma

The short interest data have been released for the May 13 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
graph

8 Stocks on the Move After ASCO Cancer Abstracts

The American Society of Clinical Oncology (ASCO) is in the process of setting up for its annual meeting in Chicago. In this meeting, companies and cancer drug developers will share ...
Read Full Story »
white pills

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
coins

Bristol-Myers Squibb Offers Up Solid Earnings Beat and Lifts Guidance

Bristol-Myers Squibb Co. (NYSE: BMY) released its first-quarter financial results before the markets opened on Thursday. The company said it had $0.74 in earnings per share (EPS) on $4.4 billion ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The short interest data have been released for the April 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the March 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
dividends

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

We are just about to wrap up the first quarter, and we could very well end where we started the year. After a brutal January and February sell-off that took ...
Read Full Story »
Medicine pills

Jefferies Top Drug Stocks for the Rest of 2016

One key analyst firm is continuing to look at which companies in the health care space are going to return the most in 2016. For the most part, Jefferies maintained ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Takes a Small Step Back

The short interest data have been released for the February 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Short Sellers Increase Bets in Major Pharma

The short interest data have been released for the February 12 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »